Granules India's Stock Sees Dip, But Moving Averages Remain Positive

Granules India, a midcap pharmaceutical company, has recently faced a dip in its stock performance. On September 12, 2024, the company's stock lost -5.78%, underperforming the sector by -6.14%. This has led to a consecutive fall for the last two days, with a total decline of -6.63% during this period.

The stock's performance today was also reflected in its intraday low of Rs 638.55, a decrease of -5.99%. However, despite this recent dip, Granules India's moving averages remain positive, with the stock being higher than the 50-day, 100-day, and 200-day moving averages. It is worth noting that the stock is currently lower than the 5-day and 20-day moving averages.

In comparison to the overall market performance, Granules India's stock has underperformed. On the same day, the Sensex saw a positive performance of 0.21%, while Granules India's stock saw a decline of -5.33%. Similarly, in the last month, the stock has seen a decline of -6.69%, while the Sensex has seen a positive performance of 2.57%.

Despite this recent dip in stock performance, MarketsMOJO has given a 'Buy' call for Granules India's stock. With a positive and informative tone, it is clear that Granules India remains a strong player in the pharmaceutical industry, with potential for growth and success in the future.